| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
1,068,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
2,207,751 |
Avg
Vol: |
993,785 |
| 52
Week Range: |
$0.007 - $0.007 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Delivery |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Generex Biotechnology is a healthcare holding company. Through its subsidiaries, Co. provides end-to-end solutions for physicians and patients. Co.'s majority-owned subsidiary, Olaregen Therapeutix, Inc. (Olaregan), is a regenerative medicine company focused on the development, manufacturing and commercialization of products that fill unmet needs in the wound care market. Olaregen's product, Excellagen® (wound conforming matrix) is a topically applied product for dermal wounds and other indications. Co.'s majority-owned subsidiary, Regentys Corporation, is a regenerative medicine company developing a tissue engineered therapy for the treatment of ulcerative colitis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gluskin Anna E |
CEO & Pres. |
• • – |
2019-11-16 |
4 |
B |
$0.51 |
$5,100 |
D/D |
10,000 |
226,127 |
2.81 |
- |
|
| Prioletti Mark Joseph Se |
Director |
– • – |
2019-06-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,568 |
|
- |
|
| Salvo Lawrence Anthony Sr |
Director |
– • – |
2019-05-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
320,345 |
|
- |
|
| Haines Harold Gray |
Consultant |
– – – |
2018-12-07 |
4 |
B |
$1.03 |
$8,709 |
D/D |
8,300 |
8,000 |
2.44 |
- |
|
| Haines Harold Gray |
Consultant |
– – – |
2018-12-04 |
4 |
B |
$2.10 |
$3,169 |
D/D |
1,500 |
945 |
2.36 |
- |
|
| Brusegard David |
Chief Operating Officer |
• – – |
2016-02-16 |
4 |
OE |
$0.00 |
$1,668 |
D/D |
1,667,671 |
5,615,070 |
|
- |
|
| Fletcher Mark |
President & CEO |
• • – |
2016-02-16 |
4 |
OE |
$0.00 |
$4,447 |
D/D |
4,447,111 |
15,821,836 |
|
- |
|
| Brusegard David |
Chief Operating Officer |
• – – |
2016-02-09 |
4 |
OE |
$0.00 |
$5,584 |
D/D |
5,583,775 |
3,916,104 |
|
- |
|
| Fletcher Mark |
President & CEO |
• • – |
2016-02-09 |
4 |
OE |
$0.00 |
$14,890 |
D/D |
14,890,033 |
10,442,992 |
|
- |
|
| Barratt John P |
Director |
– • – |
2015-04-27 |
4 |
OE |
$0.00 |
$5,874 |
D/D |
5,874,162 |
5,874,162 |
|
- |
|
| Fletcher Mark |
President & CEO |
• • – |
2014-10-06 |
4 |
OE |
$0.00 |
$471 |
D/D |
470,726 |
470,726 |
|
- |
|
| Barratt John P |
Director |
– • – |
2014-10-06 |
4 |
OE |
$0.00 |
$36 |
D/D |
35,714 |
35,714 |
|
- |
|
| Mcgee Brian |
Director |
– • – |
2014-10-06 |
4 |
OE |
$0.00 |
$36 |
D/D |
35,714 |
35,714 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
|
|
